About this trial
This study aims to evaluate the efficacy of the GentleWave® System compared to conventional methods in reducing postoperative pain in patients with necrotic pulp or requiring endodontic retreatment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male and female patients from 18 years age or older (maximum of 80 years of age), both genders.
The patients in need of an endodontic intervention.
All dental groups in both arches were eligible.
Patients who do or do not experience symptoms after the endodontic intervention.
Disqualifiers
Patients< 18 years old.
fractured teeth.
Patients who were recommended extraction after the endodontic evaluation.
Trial design
Parallel
Treatments tested in this trial
GentleWave
Other interventionGentleWave System employs a degassing process that removes dissolved gases from the solution. This optimization prevents the vapor-lock effect and ensures effective energy transmission through the root canal. As the solution enters the pulp chamber, hydrodynamic cavitation occurs, creating microbubbles that implode and generate sound waves across a broad frequency spectrum
Conventional Protocol
Other interventionDelivers irrigants (NaOCl, EDTA) through a needle-syringe system, often fails to reach the entire working length. This inadequacy can result in residual bacteria and necrotic tissue, potentially compromising treatment efficacy and increasing the risk of treatment failure.
Treatment groups
Trial outcomes
Primary outcomes
To evaluate whether using the Gentlewave system demonstrates a significant reduction in the level of postoperative pain after endodontic treatment measured by the VAS (Visual Analog Scale).
Pain measurements were made using a VAS (Visual Analog Scale of 0-10. Where the value of 0 represented absence of pain and value 10 represented the greatest intensity of pain.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: